240 related articles for article (PubMed ID: 30416008)
21. Diagnosis and treatment of primary CNS lymphoma.
Korfel A; Schlegel U
Nat Rev Neurol; 2013 Jun; 9(6):317-27. PubMed ID: 23670107
[TBL] [Abstract][Full Text] [Related]
22. [The clinical analysis of primary central nervous system lymphoma in 23 patients].
Piao YZ; Li P; Liu Q; Li WL
Zhonghua Nei Ke Za Zhi; 2011 Nov; 50(11):954-7. PubMed ID: 22333130
[TBL] [Abstract][Full Text] [Related]
23. Balancing relapses versus cognitive impairment in primary central nervous system lymphoma: a single-center experience.
Chanswangphuwana C; Rojnuckarin P; Cherdchoo N; Raiyawa T; Uaprasert N
Hematology; 2018 Aug; 23(7):385-390. PubMed ID: 29256330
[TBL] [Abstract][Full Text] [Related]
24. Is there a role for radiotherapy in the primary management of primary central nervous system lymphoma? A single-centre case series.
Muirhead R; Murray EC; Bell SL; Stewart W; James A
Clin Oncol (R Coll Radiol); 2013 Jul; 25(7):400-5. PubMed ID: 23688624
[TBL] [Abstract][Full Text] [Related]
25. Intraocular lymphoma: update on diagnosis and management.
Chan CC; Wallace DJ
Cancer Control; 2004; 11(5):285-95. PubMed ID: 15377987
[TBL] [Abstract][Full Text] [Related]
26. [Primary central nervous lymphoma: what is the role for radiotherapy?].
Bellefqih S; Mezouri I; Khalil J; Bazine A; Diakité A; El Kacimi H; Kebdani T; Benjaafar N
Cancer Radiother; 2014 Nov; 18(7):685-92. PubMed ID: 25451676
[TBL] [Abstract][Full Text] [Related]
27. Primary central nervous system lymphoma in Japan: changes in clinical features, treatment, and prognosis during 1985-2004.
Shibamoto Y; Ogino H; Suzuki G; Takemoto M; Araki N; Isobe K; Tsuchida E; Nakamura K; Kenjo M; Suzuki K; Hosono M; Tokumaru S; Ishihara S; Kato E; Ii N; Hayabuchi N
Neuro Oncol; 2008 Aug; 10(4):560-8. PubMed ID: 18559969
[TBL] [Abstract][Full Text] [Related]
28. Management of elderly patients with primary central nervous system lymphoma.
Daras M; DeAngelis LM
Curr Neurol Neurosci Rep; 2013 May; 13(5):344. PubMed ID: 23564069
[TBL] [Abstract][Full Text] [Related]
29. Primary central nervous system lymphoma.
Aziz HA; Peereboom DM; Singh AD
Int Ophthalmol Clin; 2015; 55(1):111-21. PubMed ID: 25436497
[No Abstract] [Full Text] [Related]
30. Central nervous system lymphoma.
Lister A; Abrey LE; Sandlund JT
Hematology Am Soc Hematol Educ Program; 2002; ():283-96. PubMed ID: 12446428
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of primary central nervous system lymphoma in the immunocompetent patient].
Sierra Del Rio M; Benouaich-Amiel A; Psimaras D; Dehais C; Hoang-Xuan K
Rev Neurol (Paris); 2008; 164(6-7):569-74. PubMed ID: 18565356
[TBL] [Abstract][Full Text] [Related]
32. New approaches in primary central nervous system lymphoma.
Fraser E; Gruenberg K; Rubenstein JL
Chin Clin Oncol; 2015 Mar; 4(1):11. PubMed ID: 25841718
[TBL] [Abstract][Full Text] [Related]
33. High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group.
Kasenda B; Ihorst G; Schroers R; Korfel A; Schmidt-Wolf I; Egerer G; von Baumgarten L; Röth A; Bloehdorn J; Möhle R; Binder M; Keller U; Lamprecht M; Pfreundschuh M; Valk E; Fricker H; Schorb E; Fritsch K; Finke J; Illerhaus G
Leukemia; 2017 Dec; 31(12):2623-2629. PubMed ID: 28559537
[TBL] [Abstract][Full Text] [Related]
34. High-dose chemotherapy and autologous stem cell transplantation for primary central nervous system lymphoma: a multi-centre retrospective analysis from the United Kingdom.
Kassam S; Chernucha E; O'Neill A; Hemmaway C; Cummins T; Montoto S; Lennard A; Adams G; Linton K; McKay P; Davies D; Rowntree C; Easdale S; Eyre TA; Marcus R; Cwynarski K; Fox CP
Bone Marrow Transplant; 2017 Sep; 52(9):1268-1272. PubMed ID: 28581466
[TBL] [Abstract][Full Text] [Related]
35. Treatment options for central nervous system lymphomas in immunocompetent patients.
Jahnke K; Thiel E
Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology.
Hoang-Xuan K; Bessell E; Bromberg J; Hottinger AF; Preusser M; Rudà R; Schlegel U; Siegal T; Soussain C; Abacioglu U; Cassoux N; Deckert M; Dirven CM; Ferreri AJ; Graus F; Henriksson R; Herrlinger U; Taphoorn M; Soffietti R; Weller M;
Lancet Oncol; 2015 Jul; 16(7):e322-32. PubMed ID: 26149884
[TBL] [Abstract][Full Text] [Related]
37. Progress in central nervous system lymphomas.
Wang CC; Carnevale J; Rubenstein JL
Br J Haematol; 2014 Aug; 166(3):311-25. PubMed ID: 24837460
[TBL] [Abstract][Full Text] [Related]
38. Primary central nervous system lymphoma: a review.
McAllister LD
Curr Neurol Neurosci Rep; 2002 May; 2(3):210-5. PubMed ID: 11936999
[TBL] [Abstract][Full Text] [Related]
39. Primary central nervous system lymphoma: recent progress, many remaining questions.
Swinnen LJ
Curr Opin Oncol; 2009 Sep; 21(5):393-6. PubMed ID: 19593137
[TBL] [Abstract][Full Text] [Related]
40. Primary central nervous system lymphoma as a neurosurgical problem.
Szczepanek D; Wąsik-Szczepanek E; Stoma F; Sokołowska B; Trojanowski T
Neurol Neurochir Pol; 2017; 51(4):319-323. PubMed ID: 28476199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]